Analysts Boost Earnings Outlook for Bausch Health Companies in 2024

Investment analysts have upgraded their earnings forecasts for Bausch Health Companies Inc. (NYSE:BHC), projecting a 2024 EPS of $3.59, slightly above previous estimates. With recent upgrades to a ‘buy’ rating and a price target increase from $7.00 to $9.00, confidence in Bausch Health’s stock is growing. Despite a recent quarterly EPS of $0.59 falling short of expectations, analysts remain focused on the company’s potential in the healthcare market.